Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Prescription Drug Prices
U.S. House Introduces Updated Value-Based Incentive Legislation
The House Ways & Means Health Subcommittee recently released updated draft legislation that would establish value-based…
President-Elect Donald Trump on the Pharmaceutical Industry
On Wednesday, January 11, 2017, President-Elect Donald Trump held a news conference in New York; a conference that was held out…
OIG Report Addresses High Federal Spending on Catastrophic Part D Coverage
The Department of Health and Human Services (HHS) Office of Inspector General (OIG) today released a report examining federal…
Analysis Shows Health Care Cost Predictions Grossly Incorrect
The Partnership for Health Analytics Research (PHAR, LLC), a leading health services research consultancy, recently conducted a…
Why Do People Believe Drugs Are Too Expensive?
We have long heard from the media that the pharmaceutical industry “over charges” for prescription drugs and “makes money at the…
Updated Medicare and Medicaid Drug Spending Data Released
On November 15, 2016, the Centers for Medicare and Medicaid Services (CMS) released updated Medicare and Medicaid drug spending…
AHR Holds Congressional Briefing Focused on Cost Growth
The Alliance for Health Reform recently held a Congressional briefing about cost growth of pharmaceuticals in the Medicare program…
MACPAC Focus on Drug Pricing
On October 27, 2016, the Medicaid and CHIP Payment and Access Commission’s (MACPAC) October public meeting, the Commission…
Mylan Reaches Deal Over EpiPen Rebates
On October 7, 2016, Mylan announced it reached an agreement with the United States Department of Justice (DOJ) to settle claims…
Value Frameworks: Are They the Way of the Future?
Pharmaceutical companies have long been dealing with negative press about the supposed “rise of prescription drug costs.” Now,…